Assessment of Urinary Epidermal Growth Factor Level in Patients With Chronic Kidney Disease

Urology & Nephrology Open Access Journal
doi 10.15406/unoaj.2018.06.00220
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MedCrave Group, LLC

Related search

Fibroblast Growth Factor 23 and Cardiovascular Disease in Patients With Chronic Kidney Disease

Renal Replacement Therapy
2018English

Assessment of Urinary Kim-1 as Renal Injury Marker in Chronic Kidney Disease Patients.

2019English

Epidermal Growth Factor as a Prognostic Biomarker in Chronic Kidney Diseases

Annals of Translational Medicine
Medicine
2016English

Role of Epidermal Growth Factor Receptor in Acute and Chronic Kidney Injury

Kidney International
Nephrology
2013English

Urinary Transforming Growth Factor-Beta 1 (uTGF-β1) and Prevalent Chronic Kidney Disease Risk in HIV-positive Patients in West Africa

Kidney International Reports
Nephrology
2019English

Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

JAMA - Journal of the American Medical Association
Medicine
2011English

Pitfalls of Nutritional Assessment and Support in Patients With Chronic Kidney Disease

Clinical Nutrition ESPEN
EndocrinologyNutritionMetabolismDieteticsDiabetes
2016English

Urinary Tract Aspergillosis in a Patient With Chronic Kidney Disease

BMJ Case Reports
Medicine
2017English

Sonographic Assessment of Thyroid Gland in Patients With Chronic Kidney Disease Undergoing Hemodialysis

International Journal of Diagnostic Imaging
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy